The first dendritic cell-based therapeutic cancer vaccine is approved by the FDA.
A-O
AO
Hovden
S
S
Appel
D019496:Cancer Vaccines / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003713:Dendritic Cells / Q000276:immunology*; D017277:Drug Approval; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D019496:Cancer Vaccines